Laboratory Corporation of America Holdings
NYSE:LH
Intrinsic Value
Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. [ Read More ]
The intrinsic value of one
LH
stock under the Base Case scenario is
221
USD.
Compared to the current market price of 199.45 USD,
Laboratory Corporation of America Holdings
is
Undervalued by 10%.
Laboratory Corporation of America Holdings's market capitalization is 16.7B USD.
LH stock price is 199.45 USD.
LH stock price (199.45 USD) is 10% less than its Intrinsic Value (221 USD).
LH stock price (199.45 USD) is 29% less than its Relative Value (280.8 USD). Open Relative Valuation
LH has positive Net Income for the last twelve months.
LH has positive three-year average ROIC (Return on Invested Capital): 11%. The company is efficient at using invested capital to generate operating income.
LH's Revenue is forecast to grow at a rate of 6% per year over the next 3 years.
LH's short-term assets (4B USD) exceed its short-term liabilties (3B USD).
LH's ROE (Return on Equity) for the past 12 months is very low and is equal to 5%.
LH's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 4%.
LH has positive Operating Income for the last twelve months.
LH's Revenue has been falling by 5% per year for the last 3 years.
LH's Revenue has dropped by 18% over the past 12 months.
LH's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 17% to 4%.
LH has positive three-year average ROE (Return on Equity): 18%. The company is efficient at transforming stockholders' equity into net income.
LH's Altman Z-Score is equal to 2.9.
LH has positive Gross Profit for the last twelve months.
LH has positive Free Cash Flow for the last twelve months.
LH's ROE (Return on Equity) has significantly decreased in the last 3 years from 31% to 5%.
LH's long-term assets (17B USD) exceed its long-term liabilties (9B USD).
LH's D/E (Debt to Equity) is very low and is equal to 0.52.
LH has positive Net Debt. This means that the company has more debt (4B USD) than cash and short-term investments (537m USD).
LH generates enough operating income (1B USD) to cover interest payments on its debt (222m USD).
Valuation Backtest
Laboratory Corporation of America Holdings
Run backtest to discover the historical profit from buying and selling
LH
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Laboratory Corporation of America Holdings
Balance Sheet Decomposition
Laboratory Corporation of America Holdings
| Current Assets | 3.8B |
| Cash & Short-Term Investments | 536.8m |
| Receivables | 2.1B |
| Other Current Assets | 1.1B |
| Non-Current Assets | 13B |
| Long-Term Investments | 26.9m |
| PP&E | 2.9B |
| Intangibles | 9.5B |
| Other Non-Current Assets | 536.5m |
| Current Liabilities | 3.2B |
| Accounts Payable | 827.5m |
| Accrued Liabilities | 969.8m |
| Other Current Liabilities | 1.4B |
| Non-Current Liabilities | 5.6B |
| Long-Term Debt | 4.1B |
| Other Non-Current Liabilities | 1.5B |
Earnings Waterfall
Laboratory Corporation of America Holdings
|
Revenue
|
12.2B
USD
|
|
Cost of Revenue
|
-8.8B
USD
|
|
Gross Profit
|
3.4B
USD
|
|
Operating Expenses
|
-2.2B
USD
|
|
Operating Income
|
1.1B
USD
|
|
Other Expenses
|
-705.7m
USD
|
|
Net Income
|
418m
USD
|
Free Cash Flow Analysis
Laboratory Corporation of America Holdings
What is Free Cash Flow?
LH Profitability Score
Profitability Due Diligence
Laboratory Corporation of America Holdings's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Laboratory Corporation of America Holdings's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
LH Solvency Score
Solvency Due Diligence
Laboratory Corporation of America Holdings's solvency score is 46/100. The higher the solvency score, the more solvent the company is.
Score
Laboratory Corporation of America Holdings's solvency score is 46/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LH Price Targets Summary
Laboratory Corporation of America Holdings
According to Wall Street analysts, the average 1-year price target for
LH
is 251.06 USD
with a low forecast of 222.2 USD and a high forecast of 283.5 USD.
Ownership
LH Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
LH Price
Laboratory Corporation of America Holdings
| Average Annual Return | 16.1% |
| Standard Deviation of Annual Returns | 26.94% |
| Max Drawdown | -47% |
| Market Capitalization | 16.7B USD |
| Shares Outstanding | 84 900 000 |
| Percentage of Shares Shorted | 3.11% |
Company Profile
Laboratory Corporation of America Holdings
Country
Industry
Market Cap
Dividend Yield
Description
Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 75,500 full-time employees. The Company’s business segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). Through its Dx and DD segments, the Company provides diagnostic, drug development and technology enabled solutions. The firm also supports clinical trial activity in approximately 100 countries through its industry central laboratory, preclinical, and clinical development businesses. Dx segment operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. DD segment, which operates on a global scale. The firm serves a range of customers, including doctors, hospitals, pharmaceutical companies, researchers, governmental agencies, physicians and other healthcare providers. The company also helps in delivering non-clinical testing services.
Contact
IPO
Employees
Officers
The intrinsic value of one
LH
stock under the Base Case scenario is
221
USD.
Compared to the current market price of 199.45 USD,
Laboratory Corporation of America Holdings
is
Undervalued by 10%.
You don't have any saved screeners yet
